Literature DB >> 17347081

[The surgical treatment of atrial fibrillation].

Belhhan Akpinar1, Ertan Sağbaş, Mustafa Güden, Ilhan Sanisoğlu.   

Abstract

The surgical treatment of atrial fibrillation (AF) has entered a new era with the development of new tools and advanced techniques. The Maze III operation remains as the gold standard for the surgical treatment of AF. However new energy sources have been adopted for treating this arrhythmia in an effort to reduce the invasiveness and technical concerns with the original procedure. Success rates ranging between 70-98% have been reported using these new techniques. On the other hand, interventional cardiologists have further improved their techniques so that percutaneous techniques are competing with minimally invasive ablation techniques for the treatment of drug resistant and symptomatic lone AF. These developments have aroused the interest of cardiac surgeons in AF surgery and have found themselves a wide application. It has been estimated that thirty thousand patients have undergone surgical ablation for AF so far. Inevitably, procedure related complications have occurred and caused skepticism by some groups. However, surgical ablation has become a widely accepted treatment modality for AF patients undergoing concomitant cardiac surgery. The aim of this text is to make an overall review of the surgical treatment of AF and evaluate the current situation in view of the literature and the personal experience of the authors.

Entities:  

Mesh:

Year:  2007        PMID: 17347081

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  1 in total

1.  Application of cryoablation for the treatment of atrial fibrillation in patients undergoing cardiac surgery: Our mid-term results.

Authors:  Ahmet Arnaz; A Ümit Güllü; Ahmet Akyol; Ertuğrul Zencirci; Şahin Şenay; Aleks Değirmencioğlu; Muharrem Koçyiğit; Cem Alhan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.